Editor’s introduction to the initial issue of the fifth volume of GaBI Journal

Author(s): Professor Philip D Walson, MD

This issue begins with a Letter to the Editor by Professor Fabio V Teixeira from the Brazilian Inflammatory Bowel Disease (IBD) Society that deals basically with the issue of extrapolation of indications. The letter states that ‘vigilance remains essential’ for the use of this agent in IBD patients. Professor Teixeira’s letter is in response to […]

Read more →